Synapse: Law for Life Sciences

 

 

 

 

Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.

Planning for Brexit - find out what your need to know for your business
View our Global IP Index map and compare IP regimes around the world
Taylor Wessing launches the Taylor Wessing Patent Map
The Unified Patent Court guide
Subscribe to Synapse

Medicines and medical devices regulation post-Brexit

 

Tim Worden and Matthew Royle discuss the impact of Brexit on the life sciences sector and the possible models that could be followed when renegotiating the UK's relationship with the EU.

 

 

arrowView our previous articles

Topical Issues

 

Pemetrexed update – decision of the German Federal Court of Justice now published

The German Federal Court of Justice's landmark decision in Eli Lilly v Actavis clarifies the German doctrine of equivalence and impacts on the scope of protection for Swiss-type claims. read more

 

Data exclusivity for innovators - a bridge too far?

The High Court has ruled that a generic applicant can rely on bridging data submitted by a different applicant to support an earlier application under Article 10 of Directive 2001/83/EC. read more

 

Location of the EMA after Brexit

The UK's recent vote to leave the EU raises the question of whether the EMA can stay where it currently is.... read more

 

Damages in Trade Secrets Cases - "Derived Products"

James Marshall discusses the English Court of Appeal's approach to damages in respect of sales of products derived.... read more

 

Subscribe to Synapse

Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...
Register here